Article
TLR3 polymorphism protects against multiple sclerosis onset but not progression in Egyptian patients.
Multiple sclerosis and related disorders - 1 Aug 2026
Mohsen Esraa, Haffez Hesham, Ahmed Sandra, Hamed Selwan, El-Mahdy Taghrid S
Abstract excerpt
INTRODUCTION: Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of the CNS that results from complex interactions between the peripheral and the central immune systems through proinflammatory cytokine secretion. AIMS: The present study aimed to 1: estimate the associated risk of single nucleotide polymorphisms (SNPs) in genes regulating the immune responses, namely, Toll like receptor 3...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
